Publications by authors named "Anastasios Grivas"

Claim this Profile
R
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Helena Linardou, Sofia Lampaki, Georgia-Angeliki Koliou, Athanassios Vozikis, Anastasios Boutis, Anastasios Grivas

Anticancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study.
Serafeim Chlapoutakis, Vasiliki Epameinondas Georgakopoulou, Nikolaos Trakas, Georgios Kouvelos, Petros Papalexis, Anastasios Grivas

Oncol Lett· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
Athina Christopoulou, Alexandros Ardavanis, Christos Papandreou, Georgios Koumakis, Georgios Papatsimpas, Anastasios Grivas

Oncol Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.
Giannis Mountzios, Sofia Lampaki, Georgia-Angeliki Koliou, Athanassios Vozikis, Ioannis Kontogiorgos, Anastasios Grivas

Lung Cancer (Auckl)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Nikolaos Tsoukalas, Pavlos Papakotoulas, Athina Christopoulou, Alexandros Ardavanis, Georgios Koumakis, Anastasios Grivas

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant.
Evangelos Fergadis, Abraam Assi, Eleftheria Kranidioti, Aikaterini Kosma, Maria Karakosta, Anastasios Grivas

Clin Lymphoma Myeloma Leuk· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.
Pavlos Papakotoulas, Nikolaos Tsoukalas, Athina Christopoulou, Alexandros Ardavanis, Georgios Koumakis, Anastasios Grivas

Anticancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor to Tumor Metastasis from Adenocarcinoma Not Otherwise Specified of the Parotid Gland to Uterine Leiomyoma: Presentation of a Unique Case.
Alexandros Psarris, Nektarios Koufopoulos, Anastasios Grivas, Dimitrios C Papatheodorou, Lubna Khaldi

Cureus· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; .
Christos Kosmas, Eleftheria Kranidioti, Aikaterini Kosma, Maria Karakosta, Constantinos Miltiadous, Anastasios Grivas

Leuk Lymphoma· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event.
Nikolaos Mitsimponas, Evangelia Klouva, Dimitrios Tryfonopoulos, Anastasios Grivas, Stamatina Demiri

Case Rep Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab.
John Syrios, Evelina Pappa, Nikolaos Volakakis, Anastasios Grivas, John Alafis

Breast Cancer (Auckl)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece.
Olga Triantafyllidou, Ioannis S Vlachos, Paraskevi Apostolou, Irene Konstantopoulou, Anastasios Grivas

J BUON· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic carcinoma: what after disease progression?
John Syrios, Nickolas Diamantis, Marios Panou, Anastasios Grivas, Evangelos Lianos

J BUON· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico/in vitro study of hybrid D-modified steroidal alkylator anticancer activity using uridine phosphorylase as target protein.
George D Geromichalos, Elena Geromichalou, Charalambos Camoutsis, Michael Kontos, Panagiotis Dalezis, Anastasios A Grivas

Anticancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.
Georgia Thodi, Florentia Fostira, Raphael Sandaltzopoulos, George Nasioulas, Anastasios Grivas

BMC Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2E1 and risk of chemically mediated cancers.
Dimitrios T Trafalis, Eleftheria S Panteli, Anastasios Grivas, Christos Tsigris, Petros N Karamanakos

Expert Opin Drug Metab Toxicol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis